Jazz Pharmaceuticals PLC (NAS:JAZZ)
$ 109.74 -2.27 (-2.03%) Market Cap: 6.92 Bil Enterprise Value: 11.03 Bil PE Ratio: 22.63 PB Ratio: 1.87 GF Score: 78/100

Jazz Pharmaceuticals PLC at Bank of America Healthcare Conference Transcript

May 10, 2022 / 07:40PM GMT
Release Date Price: $144.03 (+1.52%)
Jason Matthew Gerberry
BofA Securities, Research Division - MD in US Equity Research

All right, everybody. Thanks for joining us for today's afternoon session of the Bank of America Annual Healthcare Conference. My name is Jason Gerberry, I cover biotech and spec pharma. Pleased to be introducing our next company presenter, Jazz Pharmaceuticals. We've got CEO, Bruce Cozadd; Dan Swisher, President; and Philip Jochelson who is the Therapeutic Head of CNS. So Bruce has like a couple of minutes of prepared remarks, and then we'll jump into Q&A.

Bruce C. Cozadd
Jazz Pharmaceuticals plc - Co-Founder, Chairman & CEO

So how long is our session, if I talk for the whole session, then no Q&A, right?

Jason Matthew Gerberry
BofA Securities, Research Division - MD in US Equity Research

My clock is running at 27.

Bruce C. Cozadd
Jazz Pharmaceuticals plc - Co-Founder, Chairman & CEO

So Jason, it's great to be here. It's great to see people in person, it's just been

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot